These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4189600

  • 1. Treatment of drug-induced dyskinesias.
    Villeneuve A, Böszörményi Z.
    Lancet; 1970 Feb 14; 1(7642):353-4. PubMed ID: 4189600
    [No Abstract] [Full Text] [Related]

  • 2. Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
    Duvoisin RC, Marsden CD.
    Brain Res; 1974 May 10; 71(1):178-82. PubMed ID: 4821419
    [No Abstract] [Full Text] [Related]

  • 3. Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
    Reid JL, Calne DB, Vakil SD, Allen JG, Davies CA.
    J Neurol Sci; 1972 Sep 10; 17(1):45-51. PubMed ID: 4560435
    [No Abstract] [Full Text] [Related]

  • 4. Deanol in the treatment of levodopa-induced dyskinesias.
    Miller E.
    Neurology; 1974 Feb 10; 24(2):116-9. PubMed ID: 4855678
    [No Abstract] [Full Text] [Related]

  • 5. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL, Weiner WJ.
    J Neurol Neurosurg Psychiatry; 1974 Apr 10; 37(4):427-30. PubMed ID: 4838914
    [Abstract] [Full Text] [Related]

  • 6. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov 10; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 7. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 8. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ, Elizan TS, Siegel G.
    Trans Am Neurol Assoc; 1970 Jun 17; 95():286-7. PubMed ID: 5514393
    [No Abstract] [Full Text] [Related]

  • 9. Drug-induced movement disorders.
    North RR.
    Postgrad Med; 1971 Sep 17; 50(3):180-5. PubMed ID: 5092993
    [No Abstract] [Full Text] [Related]

  • 10. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
    Chase TN, Holden EM, Brody JA.
    Arch Neurol; 1973 Nov 17; 29(5):328-33. PubMed ID: 4743883
    [No Abstract] [Full Text] [Related]

  • 11. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease.
    Mones RJ, Elizan TS, Siegel GJ.
    Neurology; 1970 Apr 17; 20(4):405-6. PubMed ID: 5535050
    [No Abstract] [Full Text] [Related]

  • 12. Long-lasting dyskinesia induced by levodopa.
    Weiss JL, Ng LK, Chase TN.
    Lancet; 1971 May 15; 1(7707):1016-7. PubMed ID: 4102427
    [No Abstract] [Full Text] [Related]

  • 13. M.I.F.: effect on levodopa dyskinesias in man.
    Woods AC, Chase TN.
    Lancet; 1973 Sep 01; 2(7827):513. PubMed ID: 4125041
    [No Abstract] [Full Text] [Related]

  • 14. Sensitivity studies of L-dopa metabolites in reserpinized rats and their clinical significance.
    Ericsson AD, Wertman BG.
    Neurology; 1971 Nov 01; 21(11):1129-33. PubMed ID: 5166218
    [No Abstract] [Full Text] [Related]

  • 15. Pathophysiology of drug-induced dyskinesias.
    Korczyn AD.
    Neuropharmacology; 1972 Sep 01; 11(5):601-7. PubMed ID: 4275111
    [No Abstract] [Full Text] [Related]

  • 16. Sustained-release levodopa in parkinsonism.
    Eckstein B, Shaw K, Stern G.
    Lancet; 1973 Feb 24; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract] [Full Text] [Related]

  • 17. [Monoamines and choreic syndromes].
    Constantinidis J.
    Rev Neurol (Paris); 1972 Jul 24; 127(1):65-77. PubMed ID: 4272133
    [No Abstract] [Full Text] [Related]

  • 18. [Abnormal movements observed during treatment of Parkinson's disease with L-dopa].
    Sigwald J, Raymondeaud C.
    Rev Neurol (Paris); 1970 Feb 24; 122(2):103-12. PubMed ID: 4397165
    [No Abstract] [Full Text] [Related]

  • 19. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Fahn S.
    Neurology; 1974 May 24; 24(5):431-41. PubMed ID: 4857104
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ, Elizan TS, Siegel GJ.
    J Neurol Neurosurg Psychiatry; 1971 Dec 24; 34(6):668-73. PubMed ID: 5158780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.